FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029140623> ?p ?o ?g. }

• W2029140623 endingPage "166" @default.
• W2029140623 startingPage "159" @default.
• W2029140623 abstract "ObjectivesMajor tissue loss caused by the critical limb ischemia requires improvement of distal perfusion and cover of large tissue defects. We propose a new method, the y-shaped subscapular artery flow-through (Y-SCAFT) muscle flap using the subscapular artery that yields an arterial graft and a free muscle flap sustained by a collateral branch of this artery. This prospective study evaluated the feasibility of this technique and analyzed wound healing, graft patency, and limb salvage.MethodsBetween 2002 and 2007, 20 patients, mean age 64 years (range, 55-79 years), were treated with this technique. All presented with critical ischemia and major tissue loss, with exposure of the tendons, bones, or joint, and were candidates for major amputation. Revascularization and cover of tissue loss with the same Y-SCAFT anatomic unit was used for all patients. The distal anastomosis was performed between the distal branch of the Y-SCAFT and the pedal artery in 9, posterior tibial artery in 4, peroneal artery in 1, lateral tarsal artery in 3, and the plantar artery in 3. In four patients, the distal part of the arterial graft, including the anastomosis, was covered with the muscle flap because the tissue loss was nearby. The proximal anastomosis was performed between a leg artery and the arterial graft in 10 patients. A venous graft was necessary in 10 patients to extend the bypass proximally.ResultsOne patient died during the postoperative period. Duplex control evidenced patency all the Y-SCAFT muscle flaps. Healing was achieved in all patients. Mean follow-up was 31 months (range, 6-58 months). No patients died during follow-up. One patient presented occlusion of the Y-SCAFT muscle flap and underwent amputated. One patient had major amputation despite a patent graft. At 2 years, leg salvage was 85%, patency was 94%, and survival was 94%. At the end of the follow-up, 17 patients (1 death, 2 amputations) had a patent graft, a viable muscle flap, wound healing, and a functional leg.ConclusionWe showed the clinical feasibility of the technique of Y-SCAFT muscle flap, which allows for revascularization and cover of major tissue loss with one anatomic unit. This method is particularly useful in selected cases with poor run-off and large ischemic lesions. Major tissue loss caused by the critical limb ischemia requires improvement of distal perfusion and cover of large tissue defects. We propose a new method, the y-shaped subscapular artery flow-through (Y-SCAFT) muscle flap using the subscapular artery that yields an arterial graft and a free muscle flap sustained by a collateral branch of this artery. This prospective study evaluated the feasibility of this technique and analyzed wound healing, graft patency, and limb salvage. Between 2002 and 2007, 20 patients, mean age 64 years (range, 55-79 years), were treated with this technique. All presented with critical ischemia and major tissue loss, with exposure of the tendons, bones, or joint, and were candidates for major amputation. Revascularization and cover of tissue loss with the same Y-SCAFT anatomic unit was used for all patients. The distal anastomosis was performed between the distal branch of the Y-SCAFT and the pedal artery in 9, posterior tibial artery in 4, peroneal artery in 1, lateral tarsal artery in 3, and the plantar artery in 3. In four patients, the distal part of the arterial graft, including the anastomosis, was covered with the muscle flap because the tissue loss was nearby. The proximal anastomosis was performed between a leg artery and the arterial graft in 10 patients. A venous graft was necessary in 10 patients to extend the bypass proximally. One patient died during the postoperative period. Duplex control evidenced patency all the Y-SCAFT muscle flaps. Healing was achieved in all patients. Mean follow-up was 31 months (range, 6-58 months). No patients died during follow-up. One patient presented occlusion of the Y-SCAFT muscle flap and underwent amputated. One patient had major amputation despite a patent graft. At 2 years, leg salvage was 85%, patency was 94%, and survival was 94%. At the end of the follow-up, 17 patients (1 death, 2 amputations) had a patent graft, a viable muscle flap, wound healing, and a functional leg. We showed the clinical feasibility of the technique of Y-SCAFT muscle flap, which allows for revascularization and cover of major tissue loss with one anatomic unit. This method is particularly useful in selected cases with poor run-off and large ischemic lesions." @default.
• W2029140623 created "2016-06-24" @default.
• W2029140623 creator A5015754338 @default.
• W2029140623 creator A5019135394 @default.
• W2029140623 creator A5046143083 @default.
• W2029140623 creator A5067420839 @default.
• W2029140623 creator A5085133040 @default.
• W2029140623 date "2008-07-01" @default.
• W2029140623 modified "2023-09-25" @default.
• W2029140623 title "Subscapular artery Y-shaped flow-through muscle flap: A novel one-stage limb salvage procedure" @default.
• W2029140623 cites W1968326698 @default.
• W2029140623 cites W1983355568 @default.
• W2029140623 cites W1989013815 @default.
• W2029140623 cites W1990122711 @default.
• W2029140623 cites W2001184993 @default.
• W2029140623 cites W2001321390 @default.
• W2029140623 cites W2001858780 @default.
• W2029140623 cites W2011398423 @default.
• W2029140623 cites W2012214075 @default.
• W2029140623 cites W2012911228 @default.
• W2029140623 cites W2024290263 @default.
• W2029140623 cites W2024862925 @default.
• W2029140623 cites W2037413874 @default.
• W2029140623 cites W2038091254 @default.
• W2029140623 cites W2043517681 @default.
• W2029140623 cites W2047889742 @default.
• W2029140623 cites W2052531406 @default.
• W2029140623 cites W2055552490 @default.
• W2029140623 cites W2081032874 @default.
• W2029140623 cites W2084554784 @default.
• W2029140623 cites W2091473852 @default.
• W2029140623 cites W2098603740 @default.
• W2029140623 cites W2141256557 @default.
• W2029140623 cites W2144985796 @default.
• W2029140623 cites W2337043297 @default.
• W2029140623 cites W2410479111 @default.
• W2029140623 cites W78844522 @default.
• W2029140623 doi "https://doi.org/10.1016/j.jvs.2008.02.023" @default.
• W2029140623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18455356" @default.
• W2029140623 hasPublicationYear "2008" @default.
• W2029140623 type Work @default.
• W2029140623 sameAs 2029140623 @default.
• W2029140623 citedByCount "13" @default.
• W2029140623 countsByYear W20291406232014 @default.
• W2029140623 countsByYear W20291406232015 @default.
• W2029140623 countsByYear W20291406232016 @default.
• W2029140623 countsByYear W20291406232017 @default.
• W2029140623 countsByYear W20291406232018 @default.
• W2029140623 countsByYear W20291406232019 @default.
• W2029140623 countsByYear W20291406232020 @default.
• W2029140623 countsByYear W20291406232022 @default.
• W2029140623 crossrefType "journal-article" @default.
• W2029140623 hasAuthorship W2029140623A5015754338 @default.
• W2029140623 hasAuthorship W2029140623A5019135394 @default.
• W2029140623 hasAuthorship W2029140623A5046143083 @default.
• W2029140623 hasAuthorship W2029140623A5067420839 @default.
• W2029140623 hasAuthorship W2029140623A5085133040 @default.
• W2029140623 hasBestOaLocation W20291406231 @default.
• W2029140623 hasConcept C141071460 @default.
• W2029140623 hasConcept C164705383 @default.
• W2029140623 hasConcept C2776204877 @default.
• W2029140623 hasConcept C2776820930 @default.
• W2029140623 hasConcept C2777522714 @default.
• W2029140623 hasConcept C2779464278 @default.
• W2029140623 hasConcept C2910269628 @default.
• W2029140623 hasConcept C500558357 @default.
• W2029140623 hasConcept C541997718 @default.
• W2029140623 hasConcept C71924100 @default.
• W2029140623 hasConcept C8443397 @default.
• W2029140623 hasConceptScore W2029140623C141071460 @default.
• W2029140623 hasConceptScore W2029140623C164705383 @default.
• W2029140623 hasConceptScore W2029140623C2776204877 @default.
• W2029140623 hasConceptScore W2029140623C2776820930 @default.
• W2029140623 hasConceptScore W2029140623C2777522714 @default.
• W2029140623 hasConceptScore W2029140623C2779464278 @default.
• W2029140623 hasConceptScore W2029140623C2910269628 @default.
• W2029140623 hasConceptScore W2029140623C500558357 @default.
• W2029140623 hasConceptScore W2029140623C541997718 @default.
• W2029140623 hasConceptScore W2029140623C71924100 @default.
• W2029140623 hasConceptScore W2029140623C8443397 @default.
• W2029140623 hasIssue "1" @default.
• W2029140623 hasLocation W20291406231 @default.
• W2029140623 hasLocation W20291406232 @default.
• W2029140623 hasOpenAccess W2029140623 @default.
• W2029140623 hasPrimaryLocation W20291406231 @default.
• W2029140623 hasRelatedWork W194034296 @default.
• W2029140623 hasRelatedWork W1978164495 @default.
• W2029140623 hasRelatedWork W1990068516 @default.
• W2029140623 hasRelatedWork W20168620 @default.
• W2029140623 hasRelatedWork W2080969666 @default.
• W2029140623 hasRelatedWork W2140007129 @default.
• W2029140623 hasRelatedWork W2738864048 @default.
• W2029140623 hasRelatedWork W2947841794 @default.
• W2029140623 hasRelatedWork W3098678678 @default.
• W2029140623 hasRelatedWork W4386660062 @default.
• W2029140623 hasVolume "48" @default.
• W2029140623 isParatext "false" @default.
• W2029140623 isRetracted "false" @default.

• next